Cargando…
Metformin: a case of divide and conquer
Metformin is a widely prescribed anti-diabetic drug and its use is associated with lower cancer incidence. The mechanisms by which metformin attenuates tumorigenesis are not clearly understood. In a paper published in Proceedings of the National Academy of Sciences of the United States of America, H...
Autor principal: | Anastasiou, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672665/ https://www.ncbi.nlm.nih.gov/pubmed/23510106 http://dx.doi.org/10.1186/bcr3387 |
Ejemplares similares
-
Cheaters divide and conquer
por: Bomblies, Kirsten
Publicado: (2014) -
Angelika Amon: Conquering the divide
por: Short, Ben
Publicado: (2011) -
Divide-and-conquer Tournament on Social Networks
por: Wang, Jiasheng, et al.
Publicado: (2017) -
Precision Oncology in Sarcomas: Divide and Conquer
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2019) -
“Dividing and Conquering” and “Caching” in Molecular Modeling
por: Cao, Xiaoyong, et al.
Publicado: (2021)